$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
Weighing the Future of Weight Loss Drugs
01:44pm, Tuesday, 02'nd Jul 2024
How are obesity drugs impacting other industries? Julia Angeles discusses the future of weight loss drugs.
Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
07:15am, Tuesday, 02'nd Jul 2024
Pharmaceutical giant Pfizer Inc. NYSE: PFE has been trying to enter the weight-loss treatment trend dominated by GLP-1 drug makers like Ozempic and Wegovy makers Novo Nordisk A/S NYSE: NVO and Mounjar
1 Underwhelming Stat That May Have You Thinking Twice About Buying Pfizer's Stock
06:28am, Tuesday, 02'nd Jul 2024
Pfizer is in the midst of transition as it faces multiple patent cliffs. The company's growth strategy suggests that the business could be bigger by the end of the decade, but not necessarily by a who
3 Under-the-Radar Biotech Stocks With Blockbuster Potential
06:24am, Tuesday, 02'nd Jul 2024
One of the most important sectors in any country's economy is the biotech sector. Picking under-the-radar biotech stocks is easier said than done because we do not see immediate results.
UK court gives mixed ruling in Pfizer v Moderna COVID vaccine patents case
05:51am, Tuesday, 02'nd Jul 2024
London's High Court on Tuesday ruled that one of Moderna's patents relating to technology key to the development of vaccines for COVID-19 was invalid, but that another was valid and had been infringed
Time to Pounce: 2 Ultra-High-Yield Dividend Stocks That Are Begging to Be Bought for the Second Half of 2024 (and Beyond)
05:21am, Tuesday, 02'nd Jul 2024
Dividend stocks have a knack for running circles around non-payers over the long run. An industry-leading real estate investment trust (REIT), which has raised its payout for 107 consecutive quarters,
Pfizer: It Could Be A Bargain
01:19am, Tuesday, 02'nd Jul 2024
When excluding sales Pfizer generated due to COVID-19 vaccines and medication, the business is reporting solid growth. Especially the oncology business will drive growth in the years to come, and the
Going Beyond Morningstar's 10 Best Value Stocks List
11:57pm, Monday, 01'st Jul 2024
Morningstar published 10 Best Value Stocks to Buy for the Long Term, undervalued blue-chip stocks with low price to fair value. Valuation and future return of each stock analyzed, compared to the S&P
3 Dividend Stocks Yielding Over 3% With Multi-Decade Payout Growth Streaks
12:19pm, Monday, 01'st Jul 2024
High-yield dividend stocks have consistently attracted the attention of Wall Street investors. These stocks not only provide a steady income stream but also offer the potential for capital appreciatio
Pfizer And Moderna Vaccines Not Linked To Birth Defects, Study Finds
11:00am, Monday, 01'st Jul 2024
There is no evidence of major birth defects in babies born to mothers vaccinated against COVID-19 during the first trimester of pregnancy, according to new research published in JAMA Pediatrics on Mon
2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
10:48am, Monday, 01'st Jul 2024
The S&P 500 index is up, but not all of its components participated in the rally. Shares of Pfizer have fallen over the past year, and the stock offers a dividend yield now that's much larger than usu
2 Ultra-High-Yield Dividend Stocks Billionaires Are Buying Left and Right: Could They Be Smart Buys for You in July?
06:24am, Sunday, 30'th Jun 2024
In the U.S., people who manage large sums of money must report their trading activity to U.S. regulators every three months. In the first three months of 2024, Pfizer and Annaly Capital attracted inve
5 Highest Yielding S&P 500 Passive Income Stocks All Pay More Than Treasury Bonds
10:50am, Saturday, 29'th Jun 2024
24/7 Insights Passive income is one of the best ways to supplement Social Security or pension income.
Shhh! 7 Stocks Quietly Lining Up for a Massive Surge in July.
08:00am, Saturday, 29'th Jun 2024
Finding truly undervalued stocks to buy that are subtly poised for growth might be the difference between good returns and lost chances in the fast-paced world of investing. The emphasis is on a care
CDC Narrows Age Recommendation for Use of RSV Vaccine
12:20pm, Friday, 28'th Jun 2024
The U.S. CDC recommends that adults aged 75 years and above get an RSV shot. Those aged 60 to 74 years should only get the shot if they are at high risk for severe RSV due to chronic conditions.
Sign In
Buy PFE